The diabetes drug Byetta was linked to four more deaths in patients with pancreatitis, adding to two deaths announced by federal regulators last week.

Federal regulators are working on a stronger label for a widely used diabetes drug, Byetta, after deaths continue to be reported despite earlier government warnings.

Byetta, an injectable drug that lowers blood sugar, may help people with diabetes to live longer, according to the results of a major clinical trial.

Byetta, an injectable drug that lowers blood sugar, may help people with diabetes to live longer, according to the results of a major clinical trial.

A growing number of children are taking drugs for a wide range of chronic conditions related to childhood obesity.

Sirtris, a drug company, has two drugs in clinical trials that it hopes will avert degenerative diseases of aging like diabetes, heart disease, cancer and Alzheimer’s.